2-propyl-2-pentenoic acid
3
relevant articles (0 outcomes,
0 trials/studies)
found for this Bio-Agent
Description:
valproate metabolite; RN given refers to parent cpd
Also Known As:
(E)-2-ene valproic acid; 2-enVPA; 2-envalproic acid; 2-n-propylpent-2-enoic acid; 2-propyl-2-pentenoic acid, (E)-isomer; 2-propyl-2-pentenoic acid, (Z)-isomer; 2-propyl-2-pentenoic acid, sodium salt; E-delta(2)-valproic acid; delta2,3 VPE; delta2-valproic acid; trans-2-en-VPA; trans-2-en-valproate; trans-2-ene-valproic acid
Bio-Agent Context: Research Results
Related Diseases
| 1. | Seizures (Seizure)
02/01/1992
- " The anticonvulsant potency of trans-2-en-VPA appeared to be higher than that of VPA, especially in the case of secondarily generalized seizures" 02/01/1992
- " As in the case of VPA, trans-2-en-VPA exerted potent anticonvulsant effects against partial seizures and secondarily generalized clonic seizures in amygdala-kindled rats after i.p" 09/01/1991
- " The data show that trans-2-en-VPA exerts anticonvulsant effects against different seizure types, i.e., myoclonic, clonic, and tonic seizures in rodents and (myo)clonic seizures in dogs" 02/01/1992
- " However, as previously reported for effects of valproate in the kindling model, trans-2-en-VPA exerted anticonvulsant effects against kindled seizures only at doses which were associated with motor impairment" 09/01/1991
- " In most seizure models, trans-2-en-VPA was more potent than valproate, when both compounds were compared at their individual times of peak effect"
Order ALL the reference details at left...
|
| 2. | Epilepsy (Aura)
|
| 3. | Ataxia (Dyssynergia)
|
|
Related Drugs and Biologics